{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:38:28Z","timestamp":1792625908228,"version":"4.5.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-77868-4","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T14:57:10Z","timestamp":1790089030000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["p38\u03b1 orchestrates BRAFV600E-melanoma progression and immunotherapy response via tumor fitness and immune microenvironment modulation"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7765-8914","authenticated-orcid":false,"given":"Paula","family":"Granado-Mart\u00ednez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7227-7306","authenticated-orcid":false,"given":"Kimberley","family":"McGrail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4048-8605","authenticated-orcid":false,"given":"Roberto","family":"Orsenigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ginevra","family":"Carat\u00f9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Nieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7631-4060","authenticated-orcid":false,"given":"\u00c1ngel","family":"Nebreda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Mart\u00edn-Caballero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iv\u00e1n","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herena","family":"Eixarch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9949-5901","authenticated-orcid":false,"given":"Carmen","family":"Espejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adri\u00e0","family":"Molero-Valenzuela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1526-3201","authenticated-orcid":false,"given":"Javier","family":"Hernandez-Losa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berta","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3276-1889","authenticated-orcid":false,"given":"Holger","family":"Heyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7556-7608","authenticated-orcid":false,"given":"Eva","family":"Mu\u00f1oz-Couselo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicen\u00e7","family":"Garc\u00eda-Patos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7320-3832","authenticated-orcid":false,"given":"Juan A.","family":"Recio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"key":"77868_CR1","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/ng.356","volume":"41","author":"D Dankort","year":"2009","unstructured":"Dankort, D. et al. Braf(V600E) cooperates with Pten loss to induce metastatic melanoma. Nat Genet 41, 544\u2013552 https:\/\/doi.org\/10.1038\/ng.356 (2009).","journal-title":"Nat Genet"},{"key":"77868_CR2","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1111\/j.1755-148X.2011.00908.x","volume":"24","author":"P Lopez-Bergami","year":"2011","unstructured":"Lopez-Bergami, P. The role of mitogen- and stress-activated protein kinase pathways in melanoma. Pigment Cell Melanoma Res 24, 902\u2013921 https:\/\/doi.org\/10.1111\/j.1755-148X.2011.00908.x (2011).","journal-title":"Pigment Cell Melanoma Res"},{"key":"77868_CR3","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1038\/sj.onc.1205150","volume":"21","author":"JA Recio","year":"2002","unstructured":"Recio, J. A. & Merlino, G. Hepatocyte growth factor\/scatter factor activates proliferation in melanoma cells through p38 MAPK, ATF-2 and cyclin D1. Oncogene 21, 1000\u20131008 https:\/\/doi.org\/10.1038\/sj.onc.1205150 (2002).","journal-title":"Oncogene"},{"key":"77868_CR4","first-page":"6724","volume":"62","author":"JA Recio","year":"2002","unstructured":"Recio, J. A. et al. Ink4a\/arf deficiency promotes ultraviolet radiation-induced melanomagenesis. Cancer Res 62, 6724\u20136730 (2002).","journal-title":"Cancer Res"},{"key":"77868_CR5","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/j.1755-148X.2008.00520.x","volume":"22","author":"Y Estrada","year":"2009","unstructured":"Estrada, Y., Dong, J. & Ossowski, L. Positive crosstalk between ERK and p38 in melanoma stimulates migration and in vivo proliferation. Pigment Cell Melanoma Res 22, 66\u201376 https:\/\/doi.org\/10.1111\/j.1755-148X.2008.00520.x (2009).","journal-title":"Pigment Cell Melanoma Res"},{"key":"77868_CR6","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nrc2694","volume":"9","author":"EF Wagner","year":"2009","unstructured":"Wagner, E. F. & Nebreda, A. R. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 9, 537\u2013549 https:\/\/doi.org\/10.1038\/nrc2694 (2009).","journal-title":"Nat Rev Cancer"},{"key":"77868_CR7","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1073\/pnas.92.5.1789","volume":"92","author":"Z Abdel-Malek","year":"1995","unstructured":"Abdel-Malek, Z. et al. Mitogenic and melanogenic stimulation of normal human melanocytes by melanotropic peptides. Proc Natl Acad Sci USA 92, 1789\u20131793 https:\/\/doi.org\/10.1073\/pnas.92.5.1789 (1995).","journal-title":"Proc Natl Acad Sci USA"},{"key":"77868_CR8","doi-asserted-by":"publisher","first-page":"51226","DOI":"10.1074\/jbc.M409768200","volume":"279","author":"S Corre","year":"2004","unstructured":"Corre, S. et al. UV-induced expression of key component of the tanning process, the POMC and MC1R genes, is dependent on the p-38-activated upstream stimulating factor-1 (USF-1). J Biol Chem 279, 51226\u201351233 https:\/\/doi.org\/10.1074\/jbc.M409768200 (2004).","journal-title":"J Biol Chem"},{"key":"77868_CR9","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1038\/sj.jid.5700840","volume":"127","author":"RA Newton","year":"2007","unstructured":"Newton, R. A., Cook, A. L., Roberts, D. W., Leonard, J. H. & Sturm, R. A. Post-transcriptional regulation of melanin biosynthetic enzymes by cAMP and resveratrol in human melanocytes. J Invest Dermatol 127, 2216\u20132227 https:\/\/doi.org\/10.1038\/sj.jid.5700840 (2007).","journal-title":"J Invest Dermatol"},{"key":"77868_CR10","first-page":"244","volume":"12","author":"T Hattori","year":"2001","unstructured":"Hattori, T., Hayashi, H., Chiba, T. & Onozaki, K. Activation of two distinct anti-proliferative pathways, apoptosis and p38 MAP kinase-dependent cell cycle arrest, by tumor necrosis factor in human melanoma cell line A375. Eur Cytokine Netw 12, 244\u2013252 (2001).","journal-title":"Eur Cytokine Netw"},{"key":"77868_CR11","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/onc.2011.221","volume":"31","author":"WC Huangfu","year":"2012","unstructured":"Huangfu, W. C. et al. Inflammatory signaling compromises cell responses to interferon alpha. Oncogene 31, 161\u2013172 https:\/\/doi.org\/10.1038\/onc.2011.221 (2012).","journal-title":"Oncogene"},{"key":"77868_CR12","doi-asserted-by":"publisher","first-page":"7434","DOI":"10.4049\/jimmunol.162.12.7434","volume":"162","author":"S Itoh","year":"1999","unstructured":"Itoh, S. et al. Antiproliferative effect of IL-1 is mediated by p38 mitogen-activated protein kinase in human melanoma cell A375. J Immunol 162, 7434\u20137440 (1999).","journal-title":"J Immunol"},{"key":"77868_CR13","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/j.molonc.2014.05.008","volume":"8","author":"R Linnskog","year":"2014","unstructured":"Linnskog, R., Jonsson, G., Axelsson, L., Prasad, C. P. & Andersson, T. Interleukin-6 drives melanoma cell motility through p38alpha-MAPK-dependent up-regulation of WNT5A expression. Mol Oncol 8, 1365\u20131378 https:\/\/doi.org\/10.1016\/j.molonc.2014.05.008 (2014).","journal-title":"Mol Oncol"},{"key":"77868_CR14","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.3389\/fimmu.2018.02129","volume":"9","author":"AV Bazhin","year":"2018","unstructured":"Bazhin, A. V., von Ahn, K., Fritz, J., Werner, J. & Karakhanova, S. Interferon-alpha Up-Regulates the Expression of PD-L1 Molecules on Immune Cells Through STAT3 and p38 Signaling. Front Immunol 9, 2129 https:\/\/doi.org\/10.3389\/fimmu.2018.02129 (2018).","journal-title":"Front Immunol"},{"key":"77868_CR15","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13045-020-00926-x","volume":"13","author":"J Wang","year":"2020","unstructured":"Wang, J. et al. CDK7 inhibitor THZ1 enhances antiPD-1 therapy efficacy via the p38alpha\/MYC\/PD-L1 signaling in non-small cell lung cancer. J Hematol Oncol 13, 99 https:\/\/doi.org\/10.1186\/s13045-020-00926-x (2020).","journal-title":"J Hematol Oncol"},{"key":"77868_CR16","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/j.bbamcr.2007.03.010","volume":"1773","author":"A Cuenda","year":"2007","unstructured":"Cuenda, A. & Rousseau, S. p38 MAP-kinases pathway regulation, function and role in human diseases. Biochim Biophys Acta 1773, 1358\u20131375 https:\/\/doi.org\/10.1016\/j.bbamcr.2007.03.010 (2007).","journal-title":"Biochim Biophys Acta"},{"key":"77868_CR17","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1242\/jcs.02323","volume":"118","author":"Y Posen","year":"2005","unstructured":"Posen, Y. et al. Manipulation of redox signaling in mammalian cells enabled by controlled photogeneration of reactive oxygen species. J Cell Sci 118, 1957\u20131969 https:\/\/doi.org\/10.1242\/jcs.02323 (2005).","journal-title":"J Cell Sci"},{"key":"77868_CR18","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.cellsig.2007.10.015","volume":"20","author":"D Selimovic","year":"2008","unstructured":"Selimovic, D., Hassan, M., Haikel, Y. & Hengge, U. R. Taxol-induced mitochondrial stress in melanoma cells is mediated by activation of c-Jun N-terminal kinase (JNK) and p38 pathways via uncoupling protein 2. Cell Signal 20, 311\u2013322 https:\/\/doi.org\/10.1016\/j.cellsig.2007.10.015 (2008).","journal-title":"Cell Signal"},{"key":"77868_CR19","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","volume":"357","author":"F Balkwill","year":"2001","unstructured":"Balkwill, F. & Mantovani, A. Inflammation and cancer: back to Virchow? Lancet 357, 539\u2013545 https:\/\/doi.org\/10.1016\/S0140-6736(00)04046-0 (2001).","journal-title":"Lancet"},{"key":"77868_CR20","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/372739a0","volume":"372","author":"JC Lee","year":"1994","unstructured":"Lee, J. C. et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372, 739\u2013746 https:\/\/doi.org\/10.1038\/372739a0 (1994).","journal-title":"Nature"},{"key":"77868_CR21","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/j.1600-0749.2006.00304.x","volume":"19","author":"Y Ueda","year":"2006","unstructured":"Ueda, Y. & Richmond, A. NF-kappaB activation in melanoma. Pigment Cell Res 19, 112\u2013124 https:\/\/doi.org\/10.1111\/j.1600-0749.2006.00304.x (2006).","journal-title":"Pigment Cell Res"},{"key":"77868_CR22","doi-asserted-by":"publisher","unstructured":"Youssif, C. et al. Myeloid p38alpha signaling promotes intestinal IGF-1 production and inflammation-associated tumorigenesis. EMBO Mol. Med. 10 https:\/\/doi.org\/10.15252\/emmm.201708403 (2018).","DOI":"10.15252\/emmm.201708403"},{"key":"77868_CR23","doi-asserted-by":"publisher","first-page":"E12313","DOI":"10.1073\/pnas.1814705115","volume":"115","author":"T Zheng","year":"2018","unstructured":"Zheng, T. et al. Protein kinase p38alpha signaling in dendritic cells regulates colon inflammation and tumorigenesis. Proc Natl Acad Sci USA 115, E12313\u2013E12322 https:\/\/doi.org\/10.1073\/pnas.1814705115 (2018).","journal-title":"Proc Natl Acad Sci USA"},{"key":"77868_CR24","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.ccell.2017.01.004","volume":"31","author":"KV Katlinski","year":"2017","unstructured":"Katlinski, K. V. et al. Inactivation of Interferon Receptor Promotes the Establishment of Immune Privileged Tumor Microenvironment. Cancer Cell 31, 194\u2013207 https:\/\/doi.org\/10.1016\/j.ccell.2017.01.004 (2017).","journal-title":"Cancer Cell"},{"key":"77868_CR25","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s43018-020-0064-0","volume":"1","author":"J Gui","year":"2020","unstructured":"Gui, J. et al. Activation of p38alpha stress-activated protein kinase drives the formation of the pre-metastatic niche in the lungs. Nat Cancer 1, 603\u2013619 https:\/\/doi.org\/10.1038\/s43018-020-0064-0 (2020).","journal-title":"Nat Cancer"},{"key":"77868_CR26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ccell.2018.12.001","volume":"35","author":"A Ortiz","year":"2019","unstructured":"Ortiz, A. et al. An Interferon-Driven Oxysterol-Based Defense against Tumor-Derived Extracellular Vesicles. Cancer Cell 35, 33\u201345 e36 https:\/\/doi.org\/10.1016\/j.ccell.2018.12.001 (2019).","journal-title":"Cancer Cell"},{"key":"77868_CR27","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.ccell.2020.05.004","volume":"37","author":"D Gurusamy","year":"2020","unstructured":"Gurusamy, D. et al. Multi-phenotype CRISPR-Cas9 Screen Identifies p38 Kinase as a Target for Adoptive Immunotherapies. Cancer Cell 37, 818\u2013833 e819 https:\/\/doi.org\/10.1016\/j.ccell.2020.05.004 (2020).","journal-title":"Cancer Cell"},{"key":"77868_CR28","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.ccr.2007.03.009","volume":"11","author":"P Lopez-Bergami","year":"2007","unstructured":"Lopez-Bergami, P. et al. Rewired ERK-JNK signaling pathways in melanoma. Cancer Cell 11, 447\u2013460 https:\/\/doi.org\/10.1016\/j.ccr.2007.03.009 (2007).","journal-title":"Cancer Cell"},{"key":"77868_CR29","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646\u2013674 https:\/\/doi.org\/10.1016\/j.cell.2011.02.013 (2011).","journal-title":"Cell"},{"key":"77868_CR30","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1002\/j.1460-2075.1996.tb00542.x","volume":"15","author":"R Beyaert","year":"1996","unstructured":"Beyaert, R. et al. The p38\/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor. EMBO J 15, 1914\u20131923 (1996).","journal-title":"EMBO J"},{"key":"77868_CR31","doi-asserted-by":"publisher","first-page":"8539","DOI":"10.18632\/oncotarget.3816","volume":"6","author":"J Gupta","year":"2015","unstructured":"Gupta, J. et al. Pharmacological inhibition of p38 MAPK reduces tumor growth in patient-derived xenografts from colon tumors. Oncotarget 6, 8539\u20138551 https:\/\/doi.org\/10.18632\/oncotarget.3816 (2015).","journal-title":"Oncotarget"},{"key":"77868_CR32","doi-asserted-by":"publisher","first-page":"12230","DOI":"10.1073\/pnas.92.26.12230","volume":"92","author":"L Shapiro","year":"1995","unstructured":"Shapiro, L. & Dinarello, C. A. Osmotic regulation of cytokine synthesis in vitro. Proc Natl Acad Sci USA 92, 12230\u201312234 https:\/\/doi.org\/10.1073\/pnas.92.26.12230 (1995).","journal-title":"Proc Natl Acad Sci USA"},{"key":"77868_CR33","doi-asserted-by":"publisher","unstructured":"McGrail, K. et al. Loss of Lkb1 cooperates with Braf(V600E) and ultraviolet radiation, increasing melanoma multiplicity and neural-like dedifferentiation. Mol. Oncol. https:\/\/doi.org\/10.1002\/1878-0261.13715 (2024).","DOI":"10.1002\/1878-0261.13715"},{"key":"77868_CR34","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/ng.3275","volume":"47","author":"MB Mann","year":"2015","unstructured":"Mann, M. B. et al. Transposon mutagenesis identifies genetic drivers of Braf(V600E) melanoma. Nat Genet 47, 486\u2013495 https:\/\/doi.org\/10.1038\/ng.3275 (2015).","journal-title":"Nat Genet"},{"key":"77868_CR35","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/nature13298","volume":"511","author":"A Viros","year":"2014","unstructured":"Viros, A. et al. Ultraviolet radiation accelerates BRAF-driven melanomagenesis by targeting TP53. Nature 511, 478\u2013482 https:\/\/doi.org\/10.1038\/nature13298 (2014).","journal-title":"Nature"},{"key":"77868_CR36","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1042\/BJ20100323","volume":"429","author":"A Cuadrado","year":"2010","unstructured":"Cuadrado, A. & Nebreda, A. R. Mechanisms and functions of p38 MAPK signalling. Biochem J 429, 403\u2013417 https:\/\/doi.org\/10.1042\/BJ20100323 (2010).","journal-title":"Biochem J"},{"key":"77868_CR37","first-page":"1005","volume":"28","author":"M Rastrelli","year":"2014","unstructured":"Rastrelli, M., Tropea, S., Rossi, C. R. & Alaibac, M. Melanoma: epidemiology, risk factors, pathogenesis, diagnosis and classification. In Vivo 28, 1005\u20131011 (2014).","journal-title":"In Vivo"},{"key":"77868_CR38","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s11373-007-9148-4","volume":"14","author":"L Jinlian","year":"2007","unstructured":"Jinlian, L., Yingbin, Z. & Chunbo, W. p38 MAPK in regulating cellular responses to ultraviolet radiation. J Biomed Sci 14, 303\u2013312 https:\/\/doi.org\/10.1007\/s11373-007-9148-4 (2007).","journal-title":"J Biomed Sci"},{"key":"77868_CR39","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/ng2037","volume":"39","author":"JJ Ventura","year":"2007","unstructured":"Ventura, J. J. et al. p38alpha MAP kinase is essential in lung stem and progenitor cell proliferation and differentiation. Nat Genet 39, 750\u2013758 https:\/\/doi.org\/10.1038\/ng2037 (2007).","journal-title":"Nat Genet"},{"key":"77868_CR40","doi-asserted-by":"publisher","unstructured":"McGrail, K. et al. Transcriptional reprogramming triggered by neonatal UV radiation or Lkb1 loss prevents BRAF(V600E)-induced growth arrest in melanocytes. Oncogene https:\/\/doi.org\/10.1038\/s41388-025-03339-7 (2025).","DOI":"10.1038\/s41388-025-03339-7"},{"key":"77868_CR41","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/s41577-022-00732-1","volume":"23","author":"NK Wolf","year":"2023","unstructured":"Wolf, N. K., Kissiov, D. U. & Raulet, D. H. Roles of natural killer cells in immunity to cancer, and applications to immunotherapy. Nat Rev Immunol 23, 90\u2013105 https:\/\/doi.org\/10.1038\/s41577-022-00732-1 (2023).","journal-title":"Nat Rev Immunol"},{"key":"77868_CR42","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1182\/blood-2009-11-253286","volume":"116","author":"K Juelke","year":"2010","unstructured":"Juelke, K. et al. CD62L expression identifies a unique subset of polyfunctional CD56dim NK cells. Blood 116, 1299\u20131307 https:\/\/doi.org\/10.1182\/blood-2009-11-253286 (2010).","journal-title":"Blood"},{"key":"77868_CR43","doi-asserted-by":"publisher","first-page":"6143","DOI":"10.1038\/onc.2017.209","volume":"36","author":"Y Liu","year":"2017","unstructured":"Liu, Y. et al. Increased expression of programmed cell death protein 1 on NK cells inhibits NK-cell-mediated anti-tumor function and indicates poor prognosis in digestive cancers. Oncogene 36, 6143\u20136153 https:\/\/doi.org\/10.1038\/onc.2017.209 (2017).","journal-title":"Oncogene"},{"key":"77868_CR44","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1089\/107999004323065093","volume":"24","author":"SL Sague","year":"2004","unstructured":"Sague, S. L., Tato, C., Pure, E. & Hunter, C. A. The regulation and activation of CD44 by natural killer (NK) cells and its role in the production of IFN-gamma. J Interferon Cytokine Res 24, 301\u2013309 https:\/\/doi.org\/10.1089\/107999004323065093 (2004).","journal-title":"J Interferon Cytokine Res"},{"key":"77868_CR45","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/s41577-020-00490-y","volume":"21","author":"F Veglia","year":"2021","unstructured":"Veglia, F., Sanseviero, E. & Gabrilovich, D. I. Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity. Nat Rev Immunol 21, 485\u2013498 https:\/\/doi.org\/10.1038\/s41577-020-00490-y (2021).","journal-title":"Nat Rev Immunol"},{"key":"77868_CR46","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/nrc.2016.54","volume":"16","author":"C Engblom","year":"2016","unstructured":"Engblom, C., Pfirschke, C. & Pittet, M. J. The role of myeloid cells in cancer therapies. Nat Rev Cancer 16, 447\u2013462 https:\/\/doi.org\/10.1038\/nrc.2016.54 (2016).","journal-title":"Nat Rev Cancer"},{"key":"77868_CR47","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41577-019-0210-z","volume":"20","author":"SK Wculek","year":"2020","unstructured":"Wculek, S. K. et al. Dendritic cells in cancer immunology and immunotherapy. Nat Rev Immunol 20, 7\u201324 https:\/\/doi.org\/10.1038\/s41577-019-0210-z (2020).","journal-title":"Nat Rev Immunol"},{"key":"77868_CR48","doi-asserted-by":"publisher","unstructured":"Elewaut, A. et al. Cancer cells impair monocyte-mediated T cell stimulation to evade immunity. Nature https:\/\/doi.org\/10.1038\/s41586-024-08257-4 (2024).","DOI":"10.1038\/s41586-024-08257-4"},{"key":"77868_CR49","doi-asserted-by":"publisher","first-page":"2930","DOI":"10.1172\/JCI91190","volume":"127","author":"M Ayers","year":"2017","unstructured":"Ayers, M. et al. IFN-gamma-related mRNA profile predicts clinical response to PD-1 blockade. J Clin Investig 127, 2930\u20132940 https:\/\/doi.org\/10.1172\/JCI91190 (2017).","journal-title":"J Clin Investig"},{"key":"77868_CR50","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1158\/2159-8290.CD-15-1545","volume":"6","author":"PL Chen","year":"2016","unstructured":"Chen, P. L. et al. Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade. Cancer Discov 6, 827\u2013837 https:\/\/doi.org\/10.1158\/2159-8290.CD-15-1545 (2016).","journal-title":"Cancer Discov"},{"key":"77868_CR51","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ccell.2019.01.003","volume":"35","author":"TN Gide","year":"2019","unstructured":"Gide, T. N. et al. Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1\/Anti-CTLA-4 Combined Therapy. Cancer Cell 35, 238\u2013255 e236 https:\/\/doi.org\/10.1016\/j.ccell.2019.01.003 (2019).","journal-title":"Cancer Cell"},{"key":"77868_CR52","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.cell.2017.09.028","volume":"171","author":"N Riaz","year":"2017","unstructured":"Riaz, N. et al. Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab. Cell 171, 934\u2013949 e916 https:\/\/doi.org\/10.1016\/j.cell.2017.09.028 (2017).","journal-title":"Cell"},{"key":"77868_CR53","doi-asserted-by":"publisher","first-page":"3168","DOI":"10.1158\/1078-0432.CCR-17-0270","volume":"23","author":"ML Ascierto","year":"2017","unstructured":"Ascierto, M. L. et al. Transcriptional Mechanisms of Resistance to Anti-PD-1 Therapy. Clin Cancer Res 23, 3168\u20133180 https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-0270 (2017).","journal-title":"Clin Cancer Res"},{"key":"77868_CR54","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cell.2016.02.065","volume":"165","author":"W Hugo","year":"2016","unstructured":"Hugo, W. et al. Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma. Cell 165, 35\u201344 https:\/\/doi.org\/10.1016\/j.cell.2016.02.065 (2016).","journal-title":"Cell"},{"key":"77868_CR55","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang, P. et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med 24, 1550\u20131558 https:\/\/doi.org\/10.1038\/s41591-018-0136-1 (2018).","journal-title":"Nat Med"},{"key":"77868_CR56","doi-asserted-by":"publisher","unstructured":"Neubert, N. J. et al. T cell-induced CSF1 promotes melanoma resistance to PD1 blockade. Sci. Transl. Med. 10 https:\/\/doi.org\/10.1126\/scitranslmed.aan3311 (2018).","DOI":"10.1126\/scitranslmed.aan3311"},{"key":"77868_CR57","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/pcmr.12925","volume":"34","author":"I Banik","year":"2021","unstructured":"Banik, I. et al. NRAS(Q61K) melanoma tumor formation is reduced by p38-MAPK14 activation in zebrafish models and NRAS-mutated human melanoma cells. Pigment Cell Melanoma Res 34, 150\u2013162 https:\/\/doi.org\/10.1111\/pcmr.12925 (2021).","journal-title":"Pigment Cell Melanoma Res"},{"key":"77868_CR58","doi-asserted-by":"publisher","unstructured":"Banik, I. et al. P38 Mediates Tumor Suppression through Reduced Autophagy and Actin Cytoskeleton Changes in NRAS-Mutant Melanoma. Cancers (Basel) 15 https:\/\/doi.org\/10.3390\/cancers15030877 (2023).","DOI":"10.3390\/cancers15030877"},{"key":"77868_CR59","doi-asserted-by":"publisher","first-page":"3859","DOI":"10.1128\/MCB.23.11.3859-3871.2003","volume":"23","author":"DV Bulavin","year":"2003","unstructured":"Bulavin, D. V., Kovalsky, O., Hollander, M. C. & Fornace, A. J. Jr. Loss of oncogenic H-ras-induced cell cycle arrest and p38 mitogen-activated protein kinase activation by disruption of Gadd45a. Mol Cell Biol 23, 3859\u20133871 https:\/\/doi.org\/10.1128\/MCB.23.11.3859-3871.2003 (2003).","journal-title":"Mol Cell Biol"},{"key":"77868_CR60","doi-asserted-by":"publisher","unstructured":"Martinez-Limon, A., Joaquin, M., Caballero, M., Posas, F. & de Nadal, E. The p38 Pathway: From Biology to Cancer Therapy. Int. J. Mol. Sci. 21 https:\/\/doi.org\/10.3390\/ijms21061913 (2020).","DOI":"10.3390\/ijms21061913"},{"key":"77868_CR61","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s13578-023-01175-4","volume":"13","author":"M Lepore Signorile","year":"2023","unstructured":"Lepore Signorile, M. et al. Uncoupling p38alpha nuclear and cytoplasmic functions and identification of two p38alpha phosphorylation sites on beta-catenin: implications for the Wnt signaling pathway in CRC models. Cell Biosci 13, 223 https:\/\/doi.org\/10.1186\/s13578-023-01175-4 (2023).","journal-title":"Cell Biosci"},{"key":"77868_CR62","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1158\/0008-5472.CAN-23-1200","volume":"84","author":"SP Singh","year":"2024","unstructured":"Singh, S. P. et al. Tumor Cell-Intrinsic p38 MAPK Signaling Promotes IL1alpha-Mediated Stromal Inflammation and Therapeutic Resistance in Pancreatic Cancer. Cancer Res 84, 1320\u20131332 https:\/\/doi.org\/10.1158\/0008-5472.CAN-23-1200 (2024).","journal-title":"Cancer Res"},{"key":"77868_CR63","first-page":"1684","volume":"63","author":"JA Aguirre-Ghiso","year":"2003","unstructured":"Aguirre-Ghiso, J. A., Estrada, Y., Liu, D. & Ossowski, L. ERK(MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38(SAPK). Cancer Res 63, 1684\u20131695 (2003).","journal-title":"Cancer Res"},{"key":"77868_CR64","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nrc3793","volume":"14","author":"MS Sosa","year":"2014","unstructured":"Sosa, M. S., Bragado, P. & Aguirre-Ghiso, J. A. Mechanisms of disseminated cancer cell dormancy: an awakening field. Nat Rev Cancer 14, 611\u2013622 https:\/\/doi.org\/10.1038\/nrc3793 (2014).","journal-title":"Nat Rev Cancer"},{"key":"77868_CR65","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/ng2033","volume":"39","author":"L Hui","year":"2007","unstructured":"Hui, L. et al. p38alpha suppresses normal and cancer cell proliferation by antagonizing the JNK-c-Jun pathway. Nat Genet 39, 741\u2013749 https:\/\/doi.org\/10.1038\/ng2033 (2007).","journal-title":"Nat Genet"},{"key":"77868_CR66","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/s41580-020-00322-w","volume":"22","author":"B Canovas","year":"2021","unstructured":"Canovas, B. & Nebreda, A. R. Diversity and versatility of p38 kinase signalling in health and disease. Nat Rev Mol Cell Biol 22, 346\u2013366 https:\/\/doi.org\/10.1038\/s41580-020-00322-w (2021).","journal-title":"Nat Rev Mol Cell Biol"},{"key":"77868_CR67","doi-asserted-by":"publisher","first-page":"e66933","DOI":"10.1371\/journal.pone.0066933","volume":"8","author":"E Gonzalez-Sanchez","year":"2013","unstructured":"Gonzalez-Sanchez, E. et al. Lkb1 loss promotes tumor progression of BRAF(V600E)-induced lung adenomas. PLoS One 8, e66933 https:\/\/doi.org\/10.1371\/journal.pone.0066933 (2013).","journal-title":"PLoS One"},{"key":"77868_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou, Y. et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun 10, 1523 https:\/\/doi.org\/10.1038\/s41467-019-09234-6 (2019).","journal-title":"Nat Commun"},{"key":"77868_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34907-0","volume":"13","author":"K McGrail","year":"2022","unstructured":"McGrail, K. et al. BRAF activation by metabolic stress promotes glycolysis sensitizing NRAS(Q61)-mutated melanomas to targeted therapy. Nat Commun 13, 7113 https:\/\/doi.org\/10.1038\/s41467-022-34907-0 (2022).","journal-title":"Nat Commun"},{"key":"77868_CR70","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.immuni.2021.10.020","volume":"55","author":"E Duong","year":"2022","unstructured":"Duong, E. et al. Type I interferon activates MHC class I-dressed CD11b(+) conventional dendritic cells to promote protective anti-tumor CD8(+) T cell immunity. Immunity 55, 308\u2013323 e309 https:\/\/doi.org\/10.1016\/j.immuni.2021.10.020 (2022).","journal-title":"Immunity"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77868-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77868-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77868-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:52:10Z","timestamp":1792623130000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77868-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,22]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["77868"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-77868-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,22]]},"assertion":[{"value":"14 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"11030"}}